Patent Assignment
Reel/Frame 022954/0183
Assignment of Assignor's Interest
Recorded: 2009-07-14
Pages: 7
Assignors
VENKATESH, GOPI M.
Executed: 2009-07-06
CLEVENGER, JAMES M.
Executed: 2009-07-13
GRINSTEAD, TIMOTHY
Executed: 2009-07-13
Assignee
EURAND, INC.
845 CENTER DRIVE, VANDALIA, OHIO, 45377
Covered Properties
(2)
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Application:
61/074,464 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 9, 2008
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 021214/0697 →
Assignment of Assignor's Interest
Feb 6, 2009
From: VENKATESH, GOPI; CLEVENGER, JAMES M.; GRINSTEAD, TIMOTHY
To: EURAND, INC.
Reel/Frame 022218/0570 →
Security Agreement
Feb 11, 2011
From: EURAND, INCORPORATED
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025783/0548 →
Change of Name
Oct 6, 2011
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 027028/0048 →
Release of Lien on Patents
Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name
Sep 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036640/0591 →
U.S. Patent Security Agreement
Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →